United States · Platforms & data · The Motley Fool

Prediction: $10,000 Invested in Viking Therapeutics Before Its Oral Phase 3 Readouts Could Be Worth This Much by 2028

Published by The Motley Fool · United States 46 min ago

Prediction: $10,000 Invested in Viking Therapeutics Before Its Oral Phase 3 Readouts Could Be Worth This Much by 2028 — Prediction: $10,000 Invested in Viking Therapeutics Before Its Oral Phase 3 Readouts Could Be Worth This Much by 2028 · The Motley Fool

Detailed summary

Even a small share of the weight loss drug market could lead to a substantial increase in the company's share price.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

Illinois Tool Works Inc. $ITW Stock: Retirement Systems of Alabama Lowers Holdings

Zealand Pharma GAAP EPS of -DKK 0.79, revenue of DKK 4M; updates FY2026 outlook

My wife has dementia and may outlive me. How do we prepare for long-term memory care?

NPST Q2 FY27 presentation: 50% revenue growth, RegTech momentum

How the Jensen Huang affair changes the outlook for U.S.-China relations

Fed Chair Kevin Warsh's Central Bank Reforms Come With a Significant Unintended Consequence